Cargando…

Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways

The hallmarks of ovarian cancer encompass the development of resistance, disease recurrence and poor prognosis. Ovarian cancer cells express gene signatures which pose significant challenges for cancer drug development, therapeutics, prevention and management. Despite enhancements in contemporary tu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hiss, Donavon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306947/ https://www.ncbi.nlm.nih.gov/pubmed/22481932 http://dx.doi.org/10.1155/2012/737981

Ejemplares similares

Power Surge: Renewed Interest in Nuclear Energy
por: Holton, W. Conard
Publicado: (2005)

Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells
por: Hiss, Donavon C, et al.
Publicado: (2007)

Ovarian Cancer: Biomarkers and Targeted Therapy
por: Radu, Mihaela Raluca, et al.
Publicado: (2021)

Targeting Signaling Pathways in Epithelial Ovarian Cancer
por: Smolle, Elisabeth, et al.
Publicado: (2013)

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy
por: Harbin, Laura M., et al.
Publicado: (2022)

Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier, Carole
Publicado: (2012)

Molecular Biomarkers for the Early Detection of Ovarian Cancer
por: Zhang, Ruiqian, et al.
Publicado: (2022)

Hedgehog Signaling Pathway in Ovarian Cancer
por: Szkandera, Joanna, et al.
Publicado: (2013)

Renewed interest in the progesterone receptor in breast cancer
por: Lim, Elgene, et al.
Publicado: (2016)

An Interesting Operation for Ovarian Cyst
por: Bradfield, Jno. R., et al.
Publicado: (1891)

Molecular Targeting of Notch Signaling Pathway by DAPT in Human Ovarian Cancer: Possible Anti Metastatic Effects
por: Akbarzadeh, Maryam, et al.
Publicado: (2018)

GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson's Disease: A Mini Review
por: Enogieru, Adaze Bijou, et al.
Publicado: (2019)

Targeted Therapy in Ovarian Cancer
por: Willmott, Lyndsay J., et al.
Publicado: (2010)

Understanding and Targeting Apoptotic Pathways in Ovarian Cancer
por: Al-Alem, Linah F., et al.
Publicado: (2019)

The Role and Clinical Interest of Extracellular Vesicles in Pregnancy and Ovarian Cancer
por: Kazemi, Nazanin Yeganeh, et al.
Publicado: (2021)

Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-β pathway
por: Wen, Haiyan, et al.
Publicado: (2020)

Calcium signals and potential therapy targets in ovarian cancer (Review)
por: Deng, Fengying, et al.
Publicado: (2023)

Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
por: Yan, Tianqing, et al.
Publicado: (2023)

Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer
por: Shen, Liang, et al.
Publicado: (2022)

Comment on ‘Renewed interest in the progesterone receptor in breast cancer’
por: Simone, Giovanni, et al.
Publicado: (2017)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018)

Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer
por: Wen, Wei, et al.
Publicado: (2020)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
por: Weiland, Florian, et al.
Publicado: (2012)

Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer
por: Connor, Elizabeth V., et al.
Publicado: (2019)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

RUNX1-Regulated Signaling Pathways in Ovarian Cancer
por: Chen, Yuanzhi, et al.
Publicado: (2023)

Ovarian Cancer: Opportunity for Targeted Therapy
por: Tagawa, Tomoko, et al.
Publicado: (2012)

Targeted Therapies in Epithelial Ovarian Cancer
por: Barrena Medel, Nicanor I., et al.
Publicado: (2010)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022)

BMP signaling is a therapeutic target in ovarian cancer
por: Fukuda, Tomohiko, et al.
Publicado: (2020)

Renewed Interest in Regenerative Medicine
Publicado: (2018)

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
por: Langdon, Simon P., et al.
Publicado: (2020)

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer
por: Wall, Jaclyn A., et al.
Publicado: (2020)

Melamine contamination in nutritional supplements - Is it an alarm bell for the general consumer, athletes, and ‘Weekend Warriors’?
por: Gabriels, Gary, et al.
Publicado: (2015)

Identify Biomarkers and Design Effective Multi-Target Drugs in Ovarian Cancer: Hit Network-Target Sets Model Optimizing
por: Esmaeilzadeh, Amir Abbas, et al.
Publicado: (2022)

Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer
por: Velletri, Tania, et al.
Publicado: (2021)

Early Detection Biomarkers for Ovarian Cancer
por: Sarojini, Sreeja, et al.
Publicado: (2012)

Microvesicles as Potential Ovarian Cancer Biomarkers
por: Giusti, Ilaria, et al.
Publicado: (2013)

New Predictive Biomarkers for Ovarian Cancer
por: Atallah, Ghofraan Abdulsalam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oniodjhme5vqi3okqfcgmq6qis